🚨 FDA Recalls Levothyroxine Nationwide – Check Your Thyroid Meds NOW! (July 2026)

🚨 BREAKING: Thyroid medicine levothyroxine recalled nationwide – FDA issues Class II alert for subpotent tablets distributed by Major Pharmaceuticals and Cardinal Health. Millions of Americans with hypothyroidism, goiter, or thyroid conditions take levothyroxine daily. Certain lots (25 mcg to 150 mcg) were found to deliver less active ingredient than labeled. Expiration dates range from July 2026 to January 2027. In this detailed USA NEWS PULSE report: ✅ Exact lot numbers & NDC codes to check right now ✅ What “subpotent” means for your health ✅ Symptoms of under-dosing (fatigue, weight gain, cold sensitivity & more) ✅ Class II recall explained – risk level ✅ What to do if your meds match the list (do NOT stop without doctor advice) ✅ How to get a safe replacement Full list of affected packages and expert guidance inside. Check your medicine cabinet today! 👉 Like, comment “checked my meds” if this helped you, and subscribe to USA NEWS PULSE for the latest health & FDA alerts that matter to Americans. #levothyroxine recall 2026 #levothyroxine #levothyroxine recall #fda recalls thyroid medication #thyroid drug recall #thyroid medication recalled #levothyroxine sodium #tablets recall #LevothyroxineRecall #ThyroidRecall #FDAAlert #Hypothyroidism